Recursion Pharmaceuticals, Inc.RXRX
What Recursion Pharmaceuticals, Inc. does.
Recursion is a clinical-stage TechBio company with a mission to decode biology to radically improve lives. We have advanced a portfolio of differentiated internal programs and strategic partnerships powered by our integrated drug discovery and development platform, the Recursion Operating System (OS). This platform provides end-to-end, AI-native capabilities that span from novel biological ideas through the clinic, integrating multimodal biological data generation, AI-powered small molecule synthesis, and AI-enabled clinical development. All of our technologies are designed to translate complex science into medicines that matter — faster, better, and at scale — for patients who are waiting.
Historically, it has taken over ten years and an average capitalized R&D cost of approximately $2-3.5 billion to move a drug discovery project from early discovery to an approved therapeutic, with less than 4% of drug discovery programs initiated resulting in an approved medicine. 1,2,3,4,5,6 Today, we are working to transform the traditional high-attrition, “V-shaped” discovery funnel by pivoting to a ‘T-shaped’ model. By leveraging advanced computational tools across biology, chemistry and clinical development, we aim to rapidly narrow a broad set of potential medicines to the candidates with the highest probabilities of success, with the goal to move programs through development more efficiently and with less attrition.
Revenue and profit, by fiscal year.
| Fiscal year | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Revenue | $4.0M | $10.2M | $39.8M | $44.6M | $58.8M | $74.7M |
| Net income | -$87.0M | -$186.5M | -$239.5M | -$328.1M | -$463.7M | -$644.8M |
| Free cash flow | -$51.2M | -$198.4M | -$120.6M | -$299.7M | -$372.9M | -$378.3M |
More on RXRX.
- Recursion Pharmaceuticals, Inc. summary
- Recursion Pharmaceuticals, Inc. financial statements
- Recursion Pharmaceuticals, Inc. key metrics
- Recursion Pharmaceuticals, Inc. health scores and style box
- Recursion Pharmaceuticals, Inc. earnings
- Recursion Pharmaceuticals, Inc. dividends
- Recursion Pharmaceuticals, Inc. valuation
- Recursion Pharmaceuticals, Inc. ownership and insiders
- Recursion Pharmaceuticals, Inc. peers
Figures from Recursion Pharmaceuticals, Inc.'s filings with the U.S. SEC, standardised automatically; prices are end-of-day closes. Not financial advice.